Showing results (1421-1430 of 1,482) with videos related to

Sort By:
Pageof 149
Chemmedchem|August 12, 2015
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit ListsJohannes Schiebel, Nedyalka Radeva, Helene Köster, et al.
Clinical Epigenetics|July 16, 2025
Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemiaHaeun Yang, Vladimir Li, Su Jung Park, et al.
Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.
The Journal of Organic Chemistry|December 4, 2013
Pro-apoptotic and immunostimulatory tetrahydroxanthone dimers from the endophytic fungus Phomopsis longicollaDavid Rönsberg, Abdessamad Debbab, Attila Mándi, et al.
Plos One|May 10, 2014
Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activityDante Rotili, Domenico Tarantino, Biagina Marrocco, et al.
Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Frontiers in Immunology|May 16, 2012
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin StemC A Thomson, Y Wang, L M Jackson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2014
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancerTimothy M Zagar, Zeljko Vujaskovic, Silvia Formenti, et al.
Journal of Medicinal Chemistry|May 6, 2017
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell LinesMichael Schnekenburger, Eric Goffin, Jin-Young Lee, et al.
Cancer Letters|September 12, 2018
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP releaseAloran Mazumder, Jin-Young Lee, Oualid Talhi, et al.
Pageof 149